¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò : 2023-11-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò : 2023-11-25
±³À°ÀÏÀÚ : 2023-11-25
±³À°Àå¼Ò : À¯ÇѾçÇà º»»ç °­´ç

±³À°ÁÖÁ¦ : ¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾËÄڿÿ¬±¸È¸

´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091

À̸ÞÀÏ : kasl@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 30,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 13:10~13:30 Role of PDH regulation in alcoholic hepatitis ÀÌÀαÔ(°æºÏ´ë ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 13:30~13:50 The impacts of binge alcohol drinking: multiple mechanisms of SLD ¼­¿øÈ¿(ÀÌÈ­ÀÇ´ë ¾à´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 13:50~14:10 Exploring the contribution of mitochondrial quality control factors in pathogenesis of steatotic liver diseases ±è½ÂÁø(°­¿ø´ë ÀÚ¿¬´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 14:10~14:30 Role of CXCL1 in the experimental models of MASLD and MetALD Ȳ¼ºÈ¯(ºÎ»ê´ë ¾à´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 14:50~15:10 SLD: The new nomenclature consensus updates À±ÀçÇö(Àü³²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 15:10~15:30 Impact of alcohol consumption and metabolic syndrome on liver-related outcomes ±è¹ü°æ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 15:30~15:50 Impact of alcohol consumption on extrahepatic outcomes ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 16:10~16:30 The effect of metabolic risk factor on long-term adverse outcom in prospective KaCLiF cohort ÀÓÁöÇý(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 16:30~16:50 Different risk factors of clinical outcomes between variceal bleeding and non-variceal gastrointestinal bleeding in acutely decompensated cirrhosis ¹ÚÁö¿ø(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 16:50~17:10 The Association between Alcohol Consumption and the Risk of Hepatocellular Carcinoma according to Glycemic Status Á¶ÀºÁÖ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °­´ç 17:10~17:30 prospecitve KaCLiF/ARCADE ±è¼ºÀº(ÇѸ²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò : 2023-11-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦1ȸ ÇѸ² ·Îº¿Àΰø°üÀý ½ÉÆ÷Áö¾ö : 2023-11-25
´ÙÀ½±Û 2023³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Ãß°è Çмú´ëȸ : 2023-11-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21507 ¼­¿ï ´ëÇѱٰñ°Ý°èÃÊÀ½ÆÄÇÐȸ Á¦22Â÷ ±Ù°ñ°Ý°è Áø´Ü ¹× Ä¡·á ¿¬¼ö°­Á : 2024-09-29 0 51 2024-08-12
21506 ¼­¿ï 2024³â Çѱ¹¿µ¾çÀÇÇÐȸ Ãß°è Çмú´ëȸ : 2024-09-29 0 44 2024-08-12
21505 ¼­¿ï Á¦46Â÷ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ Çмú´ëȸ : 2024-09-29 0 17 2024-08-12
21504 ¼­¿ï 2024 ´ëÇÑÄ¡¸ÅÇÐȸ Ãß°è º¸¼ö±³À° : 2024-09-29 0 26 2024-08-12
21503 ¼­¿ï ¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø ½Å°æ¿Ü°ú ⸳ 50Áֳ⠱â³ä ½ÉÆ÷Áö¾ö : 2024-09-28 0 12 2024-08-12
21502 ¼­¿ï ¼¼ºê¶õ½º ¾È°ú 139Áֳ⠱â³ä ½ÉÆ÷Áö¿ò - (Insight of cornea disease treatment and update in cataract & refractive surgery) : 2024-09-28 0 15 2024-08-12
21501 ÀüºÏ ´ëÇÑÇǺΰúÇÐȸ ÀüºÏÁöºÎȸ 118Â÷ ÇмúÁý´ãȸ : 2024-09-28 0 11 2024-08-12
21500 ¼­¿ï 2024³â ³ë¿øÀ»Áö´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ¿¬¼ö±³À° : 2024-09-28 0 12 2024-08-12
21499 ºÎ»ê ´ëÇÑÅëÁõÇÐȸ ºÎ¿ï°æÁöȸ Áý´ãȸ : 2024-09-28 0 13 2024-08-12
21498 ¼­¿ï ´ëÇѹé½ÅÇÐȸ Á¦24Â÷ Ãß°èÇмú´ëȸ : 2024-09-27 0 14 2024-08-12
21497 ´ë±¸ ´ëÇÑ´ç´¢º´ÇÐȸ 2024 ´ë»çÁúȯ ½Å¾à ¹× ±â¼ú°³¹ß ½ÉÆ÷Áö¾ö : 2024-09-27 0 19 2024-08-12
21496 Ãæ³² ´ëÇѼöºÎ¿Ü°úÇÐȸ 2024³â ¼öºÎ ¼¼ºÎÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-09-27 0 27 2024-08-12
21495 ´ë±¸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ë±¸°æºÏÁöȸ 9¿ù ¿¬¼ö°­Á : 2024-09-24 0 11 2024-08-12
21494 ÃæºÏ ÀÎÁöÀúÇÏ¿Í ¼ºÃ浿 Á¶Àý: ¾à¹°Àû, ºñ¾à¹°Àû Á¢±Ù¹ý : 2024-09-23 0 10 2024-08-12
21493 ¼­¿ï (¿Â¶óÀÎ) 2024³â Á¦9Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ ¼ö¸é´Ù¿ø°Ë»ç ±âº»±³À°°­Á : 2024-09-22 0 15 2024-08-12
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷